Methods for the treatment of abnormal involuntary movement disorders
US11564917B2 · kind B2 · utility
0Cited by
28References
32Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 2, 2017 |
| Grant date | Jan 31, 2023 |
| Priority date | — |
| Expiry date | Oct 2, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/24
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are new dosage regimens for deuterium-substituted benzoquinoline compounds, and methods for the treatment of abnormal muscular activity, movement disorders, and related conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.